With the latest approval of the novel non-factor asset, HYMPAVZI (marstacimab) expanding Pfizer's non gene therapy hemophilia portfolio, this role will be pivotal in coordinating the strategic alignment and portfolio coordination for the consumer mar Director, Portfolio, Marketing, Marketing Manager, Skills, Business Services, Patient